Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P5QW
|
|||
Former ID |
DIB020397
|
|||
Drug Name |
MQ1
|
|||
Synonyms |
MQ-1; compound (R)-10a
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C27H31N3O2
|
|||
Canonical SMILES |
CC1=C(C=CC2=CC(=CN=C12)C(C)N3CCCC3)NC(=O)C4=CC=C(C=C4)OCC5CC5
|
|||
InChI |
1S/C27H31N3O2/c1-18-25(29-27(31)21-7-10-24(11-8-21)32-17-20-5-6-20)12-9-22-15-23(16-28-26(18)22)19(2)30-13-3-4-14-30/h7-12,15-16,19-20H,3-6,13-14,17H2,1-2H3,(H,29,31)/t19-/m1/s1
|
|||
InChIKey |
DFWKNBVJNXPUBW-LJQANCHMSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Modulator (allosteric modulator) | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | The MCH(1) receptor, an anti-obesity target, is allosterically inhibited by 8-methylquinoline derivatives possessing subnanomolar binding and long residence times. Br J Pharmacol. 2014 Mar;171(5):1287-98. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.